Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Head and Neck Cancers

Although head and neck cancer is a common malignancy, there are few programs in the country that have dedicated, multidisciplinary teams to treat a large number of patients. The Vanderbilt-Ingram Cancer Center has a nationally recognized Head and Neck Cancer Program which is staffed by expert surgeons, a full-time medical oncologist and full-time radiation oncologists.

Clinical Trials for Head and Neck Cancers

17 Open Trials

Trial Type Protocol No. &
Open Date
Summary

Basic Science

VICCHN0603

04/28/2006

Effect of PI3K Inhibition in HPV Infected Cell (deidentified)

Basic Science

VICCHN0529

05/10/2005

Novel Protein Regulator of Tumor Suppressor ARF & NF-kB (NIH/2 R01 DEO13173-05) (deidentified)

Basic Science

VICCHN0530

04/08/2005

Serum Biomarkers for Head & Neck Cancer (deidentified)

Basic Science

VICCHN0356

02/04/2003

Head and Neck Tumor Tissue Repository and Clinical Database

Other

VICCSUPP1530

04/14/2015

A Patient-Centered Outcomes Study of Patients with Recurrent Head and Neck Cancer

Other

VICCHN14122

12/23/2014

A Pilot Study for a Pain Management Smartphone Application for Patients Undergoing Radiation Therapy for Locally Advanced Head and Neck Cancer

Other

VICCSUPP1224

11/19/2012

Osteonecrosis of the Jaw Case (ONJ) Registry

Other

VICCTHN1293

10/23/2012

Comparative Musculoskeletal Impairment in Patients with Head and Neck Cancer Undergoing Surgical Reconstruction with Pectoralis Major Myocutaneous Flap Vs Revascularized Free Tissue Transfer

Supportive Care

VICCHN1541

07/01/2015

A Randomized Phase III Trial of Gabapentin versus Standard of Care for Prevention and Treatment of Mucositis in Locally Advanced Head and Neck Cancer Patients Undergoing Primary or Adjuvant Chemoradiation

Supportive Care

VICCSUPP1529

06/08/2015

Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients

Supportive Care

VICCSUPP1282

08/23/2013

Feasibility and Preliminary Efficacy of Hatha Yoga in Head and Neck Cancer Survivors

Treatment

VICCHN14121

04/23/2015

A Phase II Multi-Center, Single-Arm, Global Study of MEDI4736 Monotherapy in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Treatment

VICCHN14108

04/09/2015

A Phase II Clinical Trial of Single Agent Pembrolizumab (MK-3475) in Subjects with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Who Have Failed Platinum and Cetuximab

Treatment

VICCHN1464

11/14/2014

A Phase 2, Open-label Study of the Safety and Efficacy of the Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck, Lung or Esophagus.

Treatment

ECOGHNE3311

08/29/2014

Phase II Randomized Trial of Transoral Surgical Resection Followed by Low-Dose or Standard-Dose IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer

Treatment

VICCMD1188

06/08/2012

An Open-Label, Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers

Treatment

ECOGHNE1305-M

02/11/2009

A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer